Researchers study BPC-157 peptide because of its stable molecular structure and reproducible behavior in experimental systems
during many years of clinical application, the information from post-marketing surveillance studies, the safety data from double-blind, placebo-controlled clinical trials and EVERs pharmacovigilance database demonstrate the excellent clinical safety profile of Cerebrolysin
Many use for months to years
Berlin R, Berlin H, Brante G, Pilbrant (1978) Vitamin B12 body stores during oral and parenteral treatment of pernicious anaemia
The honest summary: strong mechanistic and animal evidence, essentially no completed human efficacy trials
Water Retention : TB500 may lead to mild water retention, causing bloating or puffiness, especially at higher doses